{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:53:49Z","timestamp":1790970829177,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,2]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      This study evaluates associations between genetically predicted circulating levels of 91 inflammatory cytokines and juvenile idiopathic arthritis (JIA) susceptibility. Summary statistics for 91 circulating inflammatory cytokines were obtained from a meta-analysis of 11 cohorts comprising 14,824 participants of European ancestry. JIA summary statistics were obtained from FinnGen Release 9 and included 788 cases and 172,834 controls of European ancestry. The primary estimator was the inverse-variance weighted (IVW) random-effects model. MR-Egger, weighted median, simple mode, and weighted mode analyses were used as complementary estimators. Sensitivity analyses included the MR-Egger intercept, Mendelian Randomization Pleiotropy RESidual Sum and Outlier, Cochran\u2019s\n                      <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                      , MR-Steiger, and leave-one-out tests. The C\u2013C motif chemokine ligand 19 (CCL19) analysis used 19 independent single-nucleotide polymorphism instruments. At the nominal threshold of\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05, IVW estimates indicated associations of CCL19 (odds ratio [OR], 2.48), fibroblast growth factor 19 (OR, 0.78), and monocyte chemotactic protein 3 (OR, 0.79) with JIA. After Bonferroni correction for 91 tests (threshold\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20055.49\u2005\u00d7\u200510\n                      <jats:sup>\u22124<\/jats:sup>\n                      ), only CCL19 remained significant (IVW\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20058.93\u2005\u00d7\u200510\n                      <jats:sup>\u22128<\/jats:sup>\n                      ; adjusted\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20058.12\u2005\u00d7\u200510\n                      <jats:sup>\u22126<\/jats:sup>\n                      ). The direction of the CCL19 estimate was consistent across Mendelian randomization methods, although significant heterogeneity and attenuation after outlier correction using Mendelian Randomization Pleiotropy RESidual Sum and Outlier indicated uncertainty in its magnitude. Higher genetically predicted CCL19 levels were associated with greater JIA susceptibility in participants of European ancestry. These findings reflect genetically predicted associations rather than established causal effects and do not support clinical prediction or intervention. Independent genetic, experimental, and clinical validation is required before CCL19 can be considered a biomarker or therapeutic target.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000051005","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:01:42Z","timestamp":1790967702000},"page":"e51005","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Genetically predicted associations between inflammatory cytokines and juvenile idiopathic arthritis"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0042-6506","authenticated-orcid":false,"given":"Jian","family":"Pang","sequence":"first","affiliation":[{"name":"Department of Medical Ultrasonics, Maternal and Child Health Care Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Medical Ultrasonics, Maternal and Child Health Care Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medical Ultrasonics, Maternal and Child Health Care Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyue","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Medical Ultrasonics, Maternal and Child Health Care Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Ultrasonics, Maternal and Child Health Care Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Medical Ultrasonics, Maternal and Child Health Care Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"He","sequence":"additional","affiliation":[{"name":"Guangxi Clinical Research Center for Birth Defects, Guangxi Key Laboratory of Reproductive Health and Birth Defects Prevention, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuihua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Ultrasonics, Maternal and Child Health Care Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1546-0096-6-11","article-title":"A comprehensive review of the genetics of juvenile idiopathic arthritis.","volume":"6","author":"Prahalad","year":"2008","journal-title":"Pediatr Rheumatol Online J"},{"key":"R2-20261002","first-page":"1989","article-title":"Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort.","volume":"29","author":"Oen","year":"2002","journal-title":"J Rheumatol"},{"key":"R3-20261002","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1542\/pir.2022-005623","article-title":"Juvenile idiopathic arthritis.","volume":"44","author":"Long","year":"2023","journal-title":"Pediatr Rev"},{"key":"R4-20261002","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11926-010-0087-0","article-title":"The genetics of juvenile idiopathic arthritis: what is new in 2010?","volume":"12","author":"Angeles-Han","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"R5-20261002","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.berh.2009.08.001","article-title":"An overview of genetics of paediatric rheumatic diseases.","volume":"23","author":"Woo","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R6-20261002","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12969-020-00448-3","article-title":"Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission.","volume":"18","author":"Aranda-Valera","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"key":"R7-20261002","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s10067-017-3719-1","article-title":"Tumor necrosis factor-\u03b1 -308 A\/G gene polymorphism in children with juvenile idiopathic arthritis: relation to disease activity, damage, and functional status.","volume":"36","author":"El Gazzar","year":"2017","journal-title":"Clin Rheumatol"},{"key":"R8-20261002","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cyto.2013.01.001","article-title":"Influence of interleukin-4 gene polymorphisms and interleukin-4 serum level on susceptibility and severity of rheumatoid arthritis in Egyptian population.","volume":"61","author":"Hussein","year":"2013","journal-title":"Cytokine"},{"key":"R9-20261002","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by FOXP3.","volume":"17","author":"Lu","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"R10-20261002","doi-asserted-by":"crossref","first-page":"11740","DOI":"10.3390\/ijms231911740","article-title":"Cytokine storm-definition, causes, and implications.","volume":"23","author":"Jarczak","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R11-20261002","doi-asserted-by":"crossref","first-page":"e2004433","DOI":"10.1002\/advs.202004433","article-title":"Cytokines: from clinical significance to quantification.","volume":"8","author":"Liu","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"R12-20261002","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/978-1-4939-7274-6_29","article-title":"Mendelian randomization.","volume":"1666","author":"Grover","year":"2017","journal-title":"Methods Mol Biol"},{"key":"R13-20261002","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R14-20261002","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0962280210394459","article-title":"Using multiple genetic variants as instrumental variables for modifiable risk factors.","volume":"21","author":"Palmer","year":"2012","journal-title":"Stat Methods Med Res"},{"key":"R15-20261002","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"R16-20261002","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R17-20261002","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R18-20261002","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R19-20261002","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023.","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res"},{"key":"R20-20261002","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/gepi.22295","article-title":"A comparison of robust Mendelian randomization methods using summary data.","volume":"44","author":"Slob","year":"2020","journal-title":"Genet Epidemiol"},{"key":"R21-20261002","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R22-20261002","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R23-20261002","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/sim.6522","article-title":"Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome.","volume":"34","author":"Del Greco M","year":"2015","journal-title":"Stat Med"},{"key":"R24-20261002","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants.","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"R25-20261002","doi-asserted-by":"crossref","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data.","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"key":"R26-20261002","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.immuni.2005.02.010","article-title":"CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells.","volume":"22","author":"Marsland","year":"2005","journal-title":"Immunity"},{"key":"R27-20261002","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fcell.2019.00212","article-title":"CCL19 and CCR7 expression, signaling pathways, and adjuvant functions in viral infection and prevention.","volume":"7","author":"Yan","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"R28-20261002","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s10067-017-3712-8","article-title":"Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.","volume":"36","author":"Favalli","year":"2017","journal-title":"Clin Rheumatol"},{"key":"R29-20261002","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.4049\/jimmunol.164.8.4025","article-title":"The CC chemokine CK beta-11\/MIP-3 beta\/ELC\/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells.","volume":"164","author":"Braun","year":"2000","journal-title":"J Immunol"},{"key":"R30-20261002","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1158\/1055-9965.EPI-14-0699-T","article-title":"Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance.","volume":"23","author":"Kitahara","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R31-20261002","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1198363","article-title":"FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis.","volume":"331","author":"Kir","year":"2011","journal-title":"Science"},{"key":"R32-20261002","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice.","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"R33-20261002","doi-asserted-by":"crossref","first-page":"247ra100","DOI":"10.1126\/scitranslmed.3009098","article-title":"A nontumorigenic variant of FGF19 treats cholestatic liver diseases.","volume":"6","author":"Luo","year":"2014","journal-title":"Sci Transl Med"},{"key":"R34-20261002","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1101\/gad.184788.111","article-title":"Endocrine fibroblast growth factors 15\/19 and 21: from feast to famine.","volume":"26","author":"Potthoff","year":"2012","journal-title":"Genes Dev"},{"key":"R35-20261002","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1210\/me.2015-1155","article-title":"Minireview: roles of fibroblast growth factors 19 and 21 in metabolic regulation and chronic diseases.","volume":"29","author":"Zhang","year":"2015","journal-title":"Mol Endocrinol"},{"key":"R36-20261002","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.bbrc.2020.04.002","article-title":"Fibroblast growth factor 19 alleviates palmitic acid-induced mitochondrial dysfunction and oxidative stress via the AMPK\/PGC-1\u03b1 pathway in skeletal muscle.","volume":"526","author":"Guo","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"R37-20261002","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1172\/JCI70710","article-title":"FGF19 action in the brain induces insulin-independent glucose lowering.","volume":"123","author":"Morton","year":"2013","journal-title":"J Clin Invest"},{"key":"R38-20261002","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1365-2591.2010.01764.x","article-title":"Monocyte chemotactic protein-3: possible involvement in apical periodontitis chemotaxis.","volume":"43","author":"Dezerega","year":"2010","journal-title":"Int Endod J"},{"key":"R39-20261002","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1161\/CIRCULATIONAHA.111.035964","article-title":"Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.","volume":"124","author":"Westermann","year":"2011","journal-title":"Circulation"},{"key":"R40-20261002","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI29919","article-title":"Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites.","volume":"117","author":"Tsou","year":"2007","journal-title":"J Clin Invest"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:01:48Z","timestamp":1790967708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051005"}},"subtitle":["A Mendelian randomization study"],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":40,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000051005","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"2025-11-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}